Compare PGY & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PGY | RAPP |
|---|---|---|
| Founded | 2016 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | N/A | 2024 |
| Metric | PGY | RAPP |
|---|---|---|
| Price | $12.41 | $27.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $34.50 | ★ $47.00 |
| AVG Volume (30 Days) | ★ 5.5M | 316.8K |
| Earning Date | 02-09-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $1,301,360,000.00 | N/A |
| Revenue This Year | $18.57 | N/A |
| Revenue Next Year | $14.58 | N/A |
| P/E Ratio | $13.37 | ★ N/A |
| Revenue Growth | ★ 26.07 | N/A |
| 52 Week Low | $8.50 | $6.43 |
| 52 Week High | $44.99 | $42.27 |
| Indicator | PGY | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 24.69 | 55.76 |
| Support Level | $12.05 | $26.57 |
| Resistance Level | $15.51 | $28.99 |
| Average True Range (ATR) | 1.34 | 1.80 |
| MACD | -0.72 | 0.25 |
| Stochastic Oscillator | 4.03 | 92.06 |
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.